Nutritional beverage 10003RF
Other2 sachets per day
NCT Number: NCT01641770
The study objective is to evaluate the benefits of Oral Nutritional Supplementation (ONS) plus Dietary Counseling (DC) in newly admitted hospital subjects with moderate or severe malnutrition.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 3
King George Hospital / Andhra Medical College, Andhra Pradesh, India
Approximately 212 subjects (men and women) from multiple Institutions in India will participate in this study. Eligible subjects will be randomized into 2 treatment groups.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
2 sachets per day
Guidelines for dietary counseling include energy and nutrient requirements.
Time frame: baseline and weeks 4, 8, 12
Time frame: baseline and week 12
Time frame: baseline and week 12
Time frame: baseline and weeks 4,8,12
values and changes from baseline
Time frame: baseline and weeks 4, 8, 12
values and changes from baseline
Time frame: Baseline and weeks 4,8,12
values and changes from baseline
Time frame: Baseline and weeks 4,8,12
Values and changes from baseline
Abbott Nutrition
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02911246
Brain Diseases, Brain Injuries
Nantes, France
View Trial DetailsNCT06397118
Anemia, Anemia, Hemolytic
Nashville, Tennessee, United States
View Trial DetailsNCT04244851
Malnutrition, Nutrition Disorders
Rennes, France
View Trial DetailsNCT07620197
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Kisumu, Kenya
View Trial Details